| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.9 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |